venBio Partners is a San Francisco life-sciences venture firm founded in 2011 (co-founders Corey Goodman and Robert Adelman) that invests in companies developing biopharmaceuticals for unmet medical needs across all clinical stages, including crossover rounds and IPOs. It runs a highly concentrated, hands-on portfolio; the firm cites nine FDA approvals across its companies over six years. Fund V (venBio Global Strategic Fund V) closed oversubscribed at ~$528M in 2024.

Firm Profile

Notable Partners

Portfolio Companies (8)

Investment Focus

VCSector SpecialistSJ Top 100

Investor data reflects publicly disclosed AUM, fund sizes, and portfolio holdings as of recent date. Refreshed periodically.